Maintenance treatment of schizophrenia with paliperidone palmitate (xeplion): a naturalistic study

被引：0
|
作者：
Kolyutskaya, E. V. [1 ]
Smulevich, A. B. [1 ]
机构：
[1] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 109801, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 11期
关键词：
schizophrenia; antipsychotics; maintenance treatment; paliperidone palmitate; naturalistic study; POST-HOC ANALYSIS; ANTIPSYCHOTIC TREATMENT; DISCONTINUATION; OUTCOMES; RELAPSE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The efficacy of injectable form of paliperidone palmitate was studied in a sample of 14 schizophrenic patients (6 men and 8 women, mean age 33.8 years). Paliperidone palmitate was used as maintenance therapy in patients with remission. Duration of the study was 8 weeks. The drug was administered in doses 150 mg in the first day, 100 mg in the 8th day and 75 mg after the 4th week. Twelve (85.7%) patients responded positively to the treatment. At the end of the study, the "improvement" on CGI scale was noted in 4 patients, "minimal improvement" in 5 patients and "no change" in 3 patients. There was a significant reduction on the PANSS negative subscale. Six patients had improvement in cognitive functions. Exacerbation of positive symptoms of schizophrenia was not found. It has been concluded that injectable form of paliperidone palmitate may be recommended for maintenance treatment of schizophrenia.
引用
收藏
页码：50 / 53
页数：6
相关论文
共 50 条
  • [1] Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults
    Kim, Shiyun
    Solari, Hugo
    Weiden, Peter J.
    Bishop, Jeffrey R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 533 - 545
  • [2] Paliperidone palmitate treatment in schizophrenia
    Chinchilla, A.
    Vega, M.
    Garcia, M.
    Parro, C.
    Martinez, G.
    Centelles, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 67 - 67
  • [3] Paliperidone palmitate for schizophrenia
    Nussbaum, A. M.
    Stroup, T. S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [4] Paliperidone Palmitate for Schizophrenia
    Nussbaum, Abraham M.
    Stroup, T. Scott
    [J]. SCHIZOPHRENIA BULLETIN, 2012, 38 (06) : 1124 - 1127
  • [5] Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany
    Zeidler J.
    Mahlich J.
    Greiner W.
    Heres S.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (5) : 509 - 521
  • [6] The outcome of paliperidone palmitate in schizophrenia
    Ju, Po-Chung
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 193 - 193
  • [7] Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia A Randomized Clinical Trial
    McEvoy, Joseph P.
    Byerly, Matthew
    Hamer, Robert M.
    Dominik, Rosalie
    Swartz, Marvin S.
    Rosenheck, Robert A.
    Ray, Neepa
    Lamberti, J. Steven
    Buckley, Peter F.
    Wilkins, Tania M.
    Stroup, T. Scott
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (19): : 1978 - 1986
  • [8] Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia
    Jarema, Marek
    Bienkowski, Przemyslaw
    Heitzman, Janusz
    Parnowski, Tadeusz
    Rybakowski, Janusz
    [J]. PSYCHIATRIA POLSKA, 2017, 51 (01) : 7 - 21
  • [9] Naturalistic study of efficacy of acute treatment with paliperidone palmitate as add-on therapy in the treatment of manic inpatients
    Nieto, E.
    Carreras, J.
    Rius, M.
    Puig, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 55 - 55
  • [10] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE FOR THE TREATMENT OF SCHIZOPHRENIA IN MEXICO
    Reyes-Lopez, A.
    Querol, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A561 - A561
12345